• Epi 2 with Dr. Janani Rangaswami

  • Jun 25 2024
  • Length: 38 mins
  • Podcast

Epi 2 with Dr. Janani Rangaswami cover art

Epi 2 with Dr. Janani Rangaswami

  • Summary

  • In this episode, Dr. Rangaswami discusses "renalism" - the systematic exclusion of patients with advanced chronic kidney disease (CKD) from heart failure trials and treatments. She explains the historical reasons behind this exclusion, recent positive trends in including more CKD patients in trials, and the challenges in enrolling these patients. Dr. Rangaswami highlights the importance of representing CKD patients in research and clinical practice, noting recent developments like new risk calculators that incorporate kidney function. She also provides practical insights on using guideline-directed medical therapies in patients with advanced CKD and heart failure, including the use of newer medications and potassium binders.

    Show More Show Less

What listeners say about Epi 2 with Dr. Janani Rangaswami

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.